ArticleInternational dental journal2025
In Vitro Effects of Zinc Compounds on the Candidacidal Activities of Salivary Antimicrobials.
Article in International dental journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Efficacy of topical application of zinc compounds for oral mucosal diseases: A systematic review and meta-analysis.Medicina oral, patologia oral y cirugia bucal · 2026Pooled it
- Clinical, Immunological and Microbiological Improvements With Zinc-Coated Healing Abutments During the Healing Phase.International dental journal · 2026Trial
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to investigate the effects of zinc compounds on the candidacidal activities of lysozyme and the peroxidase (PO) and glucose oxidase-mediated peroxidase (GO-PO) systems against Candida albicans.
methodsFour zinc compounds were used: zinc chloride, gluconate, lactate, and sulphate. Three antimicrobial systems were used: hen egg-white lysozyme (HEWL), the PO system [bovine lactoperoxidase (bLPO), potassium thiocyanate, and hydrogen peroxide], and the GO-PO system (bLPO, potassium thiocyanate, glucose oxidase, and glucose). Three Candida albicans strains were used: ATCC 10231, 11006, and 18804. The candidacidal activity of each zinc compound-antimicrobial system mixture was compared with that of the zinc compound or antimicrobial system alone.
resultsThe addition of zinc chloride and gluconate significantly (P < .05) increased the candidacidal activity of HEWL in the ATCC 10231 and 11006 strains. Regarding the PO system, the addition of zinc sulphate in the ATCC 10231 strain and of zinc chloride or gluconate in the ATCC 18804 strain significantly (P < .05) increased the candidacidal activity compared with the PO system alone. No significant changes were observed in the candidacidal activities of the mixture of each zinc compound and the GO-PO system compared with the GO-PO system alone for all three C. albicans strains.
conclusionsAlthough it depended on the type of zinc compound or strain, the addition of zinc compounds increased the candidacidal activities of antimicrobial enzymes against C. albicans compared with HEWL or the PO system alone. The introduction of zinc compounds into oral healthcare products containing antimicrobials could provide additional antifungal activity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.